Following its latest earnings release, PhosAgro CEO Andrey Guryev talks about the challenges the business faces and its outlook going forward.
Lanxess CEO, Matthias Zachert talks about the transformation within the specialty chemicals company and its change in strategy.
Belgian chemicals firm Solvay has raised its guidance saying it expects double-digit EBITDA growth for the fourth quarter of 2016. Its CFO, Karim Hajjar discusses.
World's largest pesticides maker expects the deal to stretch into the first quarter of next year.
AkzoNobel CFO, Maëlys Castella, reflects on the chemicals company’s latest earnings and the challenges it faces at present.
Monsanto reported a surprise adjusted profit, helped by a drop in expenses and higher corn seed volumes.
Peder Holk Nielsen, CEO of Novozymes, discusses how the company is performing and from where growth will come.
CNBC's Geoff Cutmore speaks to Phosagro CEO Andrey Guryev, who views the recent Bayer/Monstanto deal as a positive for the agrochemical industry.
Bayer has won over Monsanto with a takeover offer of around $66 billion, ending months of wrangling after increasing its bid for a third time.
Jeremy Redenius, equity analyst for European chemicals at Bernstein, says a merger deal only has a 50 percent chance of getting regulatory approval.
Germany's Linde and U.S. peer Praxair have ended merger talks that would have created a market leader with a value of more than $60 billion.
The European Commission said the deal, which would create the world's largest integrated crop protection and seeds company, may hurt competition.
Andrew Liveris, Dow Chemical chairman & CEO, discusses the company's quarterly beat and strong performance in plastics. Also Liveris talks about the expected merger with DuPont.
John Rountree, managing partner of Novasecta, discusses earnings at Bayer and the company's progress in acquiring Monsanto.
It's not quite salt and a lime, but Ford thinks its cars and trucks could be a pretty good fit with Jose Cuervo, the famed tequila maker.
Results in the quarter were marked by currency volatility, including for the British pound.
Brexit worries weighed on chemical stocks Monday as many companies in the sector have 'significant' exposure to Europe.
The German pharmaceutical and chemicals firm Bayer has outlined a mammoth bid for a U.S. firm beset by reputational issues.
Bayer says it has offered $122 per share for Monsanto in an all-cash deal that values the U.S. company at $62 billion.
German drug and chemicals giant Bayer has made an unsolicited takeover offer for Monsanto, the world's biggest seed company.